{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:01:37Z","timestamp":1792544497761,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1524,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1365-2133.2011.10339.x","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T12:10:58Z","timestamp":1301659858000},"page":"391-398","source":"Crossref","is-referenced-by-count":172,"title":["A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa"],"prefix":"10.1093","volume":"165","author":[{"given":"I.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Lynggaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lophaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zachariae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.E.","family":"Jemec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,6,30]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB1|cit1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-33101-8","volume-title":"Hidradenitis Suppurativa","author":"Jemec","year":"2006"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2340\/0001555576482483","article-title":"A case-control study of hidradenitis suppurativa in an STD population","volume":"76","author":"Jemec","year":"1996","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1600-0625.2009.00915.x","article-title":"Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis","volume":"19","author":"von Laffert","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0190-9622(96)90277-7","article-title":"Histology of hidradenitis suppurativa","volume":"34","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2133.1990.tb06264.x","article-title":"Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands","volume":"122","author":"Yu","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","article-title":"What causes hidradenitis suppurativa?","volume":"17","author":"Kurzen","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000287261","article-title":"Hidradenitis suppurativa complicating naevus comedonicus: the possible influence of mechanical stress on the development of hidradenitis suppurativa","volume":"220","author":"Dufour","year":"2010","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2133.1996.tb03880.x","article-title":"Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions","volume":"135","author":"Boer","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.2007.08425.x","article-title":"Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor","volume":"158","author":"Hunger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.2006.07556.x","article-title":"Altered innate and adaptive immune responses in patients with hidradenitis suppurativa","volume":"156","author":"Giamarellos-Bourboulis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1517\/14656566.5.8.1767","article-title":"Medical treatment of hidradenitis suppurativa","volume":"5","author":"Jemec","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"van der Zee","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mjd.2002.124601","article-title":"Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa","volume":"47","author":"Lapins","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2133.1994.tb08559.x","article-title":"Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique","volume":"131","author":"Lapins","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa","volume":"26","author":"Rompel","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2340\/00015555-0747","article-title":"Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors","volume":"89","author":"Haslund","year":"2009","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaad.2008.11.898","article-title":"A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa","volume":"60","author":"Lee","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB28|cit28","first-page":"729","volume-title":"Dermatologic Surgery. Principles and Practice","author":"Hurley","year":"1996"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.326.7380.88","article-title":"Skin scarring","volume":"326","author":"Bayrat","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB30|cit30","volume-title":"Multiple Comparisons and Multiple Tests Using SAS","author":"Westfall","year":"1999"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijrobp.2007.01.024","article-title":"Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients","volume":"68","author":"Jereczek-Fossa","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2133.2010.09715.x","article-title":"Interobserver variability of clinical scores in hidradenitis suppurativa is low","volume":"162","author":"Sartorius","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn\u2019s disease: results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa","volume":"158","author":"Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10339.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10339.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10339.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T13:11:58Z","timestamp":1712322718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/165\/2\/391\/6644235"}},"subtitle":["Hidradenitis suppurativa and adalimumab"],"short-title":[],"issued":{"date-parts":[[2011,6,30]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10339.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.724197415.793501410","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,30]]}}}